Inside ACLA’s model for CMS/FDA oversight of IVDMIAs
Legislative outlook in 2008 for lab/pathology priorities—see the Focus
—Physician reimbursement
—Pathology TC billings by independent labs
—Repeal of lab bidding demo
—CLIA cytology proficiency testing
—Genetic discrimination prohibitions
FDA okays first test to identify 12 respiratory viruses from single sample
Pathology claims advisory
CMS to adjust fee for new metabolic panel code
Correction: Physician quality reporting program to run for all of 2008
Don’t miss LabCompete, Feb. 6-8, Tucson, AZ. Check out details at g2reports.com/LabCompete08

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

January 28, 2008 - Table of Contents

NIR January 28, 2008 (full issue PDF)

Labs Ratchet Up Game Plan to Block Lab Bidding Demo

Physician Fee Fix Issues in Flux

Regulating IVDMIAs: A Closer Look at ACLA’s Proposed Model

Legislative Outlook for Medicare Changes in 2008: Key Priorities for Clinical Labs, Pathologists

FDA Okays 1st Test to Identify 12 Respiratory Viruses

Pathology Claims Advisory

CMS to Adjust Payment for New Metabolic Panel Code